Literature DB >> 20079163

Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population.

Fang Wang1, Xue-yao Han, Qian Ren, Xiu-ying Zhang, Ling-chuan Han, Ying-ying Luo, Xiang-hai Zhou, Li-nong Ji.   

Abstract

BACKGROUND: KCNJ11, ABCC8, PPARG, and HNF4A have been found to be associated with type 2 diabetes in populations with different genetic backgrounds. The aim of this study was to test, in a Chinese Han population from Beijing, whether the genetic variants in these four genes were associated with genetic predisposition to type 2 diabetes.
METHODS: We studied the association of four representative SNPs in KCNJ11, ABCC8, PPARG, and HNF4A by genotyping them using ABI SNaPshot Multiplex System in 400 unrelated type 2 diabetic patients and 400 unrelated normoglycaemic subjects.
RESULTS: rs5219 (E23K) in KCNJ11 was associated with genetic susceptibility to type 2 diabetes (OR = 1.400 with 95% CI 1.117 1.755, P = 0.004 under an additive model, OR = 1.652 with 95% CI 1.086 2.513, P = 0.019 under a recessive model, and OR = 1.521 with 95% CI 1.089 2.123, P = 0.014 under a dominant model) after adjusting for sex and body mass index (BMI). We did not find evidence of association for ABCC8 rs1799854, PPARG rs1801282 (Pro12Ala) and HNF4A rs2144908. Genotype-phenotype correlation analysis revealed that rs1799854 in ABCC8 was associated with 2-hour postprandial insulin secretion (P = 0.005) after adjusting for sex, age and BMI. Although no interactions between the four variants on the risk of type 2 diabetes were detected, the multiplicative interaction between PPARG Pro12Ala and HNF4A rs2144908 was found to be associated with 2-hour postprandial insulin (P = 0.004 under an additive model for rs2144908; and P = 0.001 under a dominant model for rs2144908) after adjusting for age, sex and BMI, assuming a dominant model for PPARG Pro12Ala.
CONCLUSIONS: Our study replicated the association of rs5219 in KCNJ11 with type 2 diabetes in Chinese Han population in Beijing. And we also observed that ABCC8 as well as the interaction between PPARG and HNF4A may contribute to post-challenge insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20079163

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  19 in total

1.  Association between KCNJ11 gene polymorphisms and risk of type 2 diabetes mellitus in East Asian populations: a meta-analysis in 42,573 individuals.

Authors:  Lijuan Yang; Xianghai Zhou; Yingying Luo; Xiuqin Sun; Yong Tang; Wulan Guo; Xueyao Han; Linong Ji
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

2.  Association analyses between the genetic polymorphisms of HNF4A and FOXO1 genes and Chinese Han patients with type 2 diabetes.

Authors:  Tianjie Li; Xiaopan Wu; Xilin Zhu; Jingyun Li; Liping Pan; Pengtao Li; Zhenhui Xin; Ying Liu
Journal:  Mol Cell Biochem       Date:  2011-03-27       Impact factor: 3.396

3.  The KCNJ11 E23K gene polymorphism and type 2 diabetes mellitus in the Chinese Han population: a meta-analysis of 6,109 subjects.

Authors:  Yan-Yan Li
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

4.  PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet.

Authors:  Marta Garaulet; Caren E Smith; Teresa Hernández-González; Yu-Chi Lee; Jose M Ordovás
Journal:  Mol Nutr Food Res       Date:  2011-11-21       Impact factor: 5.914

Review 5.  Pharmacogenomics of sulfonylureas in type 2 diabetes mellitus; a systematic review.

Authors:  Leyla Karkhaneh; Ozra Tabatabaei-Malazy; Fatemeh Bandarian; Shahrzad Mohseni; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-12-01

6.  Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population.

Authors:  Xueyao Han; Yingying Luo; Qian Ren; Xiuying Zhang; Fang Wang; Xiuqin Sun; Xianghai Zhou; Linong Ji
Journal:  BMC Med Genet       Date:  2010-05-28       Impact factor: 2.103

7.  Implications of critical PPARγ2, ADIPOQ and FTO gene polymorphisms in type 2 diabetes and obesity-mediated susceptibility to type 2 diabetes in an Indian population.

Authors:  Nagaraja M Phani; Manik Vohra; Somyasree Rajesh; Prabha Adhikari; Shivashankara K Nagri; Sydney C D'Souza; Kapaettu Satyamoorthy; Padmalatha S Rai
Journal:  Mol Genet Genomics       Date:  2015-08-05       Impact factor: 3.291

8.  Clinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis.

Authors:  Yu Liu; Wenhui Wan; Fang Fang; Lei Guo; Yusheng Zhao; Xinghu Zhang; Fang Huang
Journal:  J Clin Lab Anal       Date:  2017-10-21       Impact factor: 2.352

9.  Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes.

Authors:  Raquel Villegas; Scott M Williams; Yu-Tang Gao; Jirong Long; Jiajun Shi; Hui Cai; Honglan Li; Ching-Chu Chen; E Shyong Tai; Frank Hu; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu
Journal:  Ann Hum Genet       Date:  2014-01       Impact factor: 1.670

10.  The association of genetic variants of type 2 diabetes with kidney function.

Authors:  Nora Franceschini; Nawar M Shara; Hong Wang; V Saroja Voruganti; Sandy Laston; Karin Haack; Elisa T Lee; Lyle G Best; Jean W Maccluer; Barbara J Cochran; Thomas D Dyer; Barbara V Howard; Shelley A Cole; Kari E North; Jason G Umans
Journal:  Kidney Int       Date:  2012-04-18       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.